Technical Analysis for BPMX - BioPharmX Corporation

Grade Last Price % Change Price Change
grade F 0.115 0.00% 0.00
BPMX closed unchanged on Friday, January 18, 2019, on 66 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical BPMX trend table...

Date Alert Name Type % Chg
Jan 18 Narrow Range Bar Range Contraction 0.00%
Jan 18 NR7 Range Contraction 0.00%
Jan 18 NR7-2 Range Contraction 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Narrow Range Bar Range Contraction 0.00%
Jan 17 NR7 Range Contraction 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 16 Wide Bands Range Expansion -4.17%
Jan 15 Narrow Range Bar Range Contraction -2.95%
Jan 15 NR7 Range Contraction -2.95%

Older signals for BPMX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

BioPharmX Corporation, a specialty pharmaceutical company, focuses on the development of novel drug delivery products for women's health, dermatology, and otolaryngology markets. The company offers prescription, over-the-counter (OTC), and supplement products in oral, topical, inhalant, and/or injectable forms. It provides VI2OLET iodine, an OTC dietary supplement molecular iodine tablet that promotes overall breast health and for the alleviation of benign breast pain associated with fibrocystic breast condition. The company's clinical-stage product candidates include BPX03, a molecular iodine tablet for the treatment of benign breast pain associated with FBC and cyclic mastalgia; and BPX01, a non-lipophilic topical antibiotic for the treatment of acne. It serves pharmaceutical companies; physician's practices, including OB-Gyn's, dermatologists, and general practioners; and retail customers through retail sales channels and/or pharmacy outlets. The company has collaboration and licensing agreement with Iogen LLC for the development of molecular iodine products; and collaboration and supply agreement with NuTech Medical, Inc. to develop products in the field of dermatology. BioPharmX Corporation is headquartered in Menlo Park, California.
Is BPMX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 0.375
52 Week Low 0.05
Average Volume 3,712,231
200-Day Moving Average 0.1869
50-Day Moving Average 0.1371
20-Day Moving Average 0.1102
10-Day Moving Average 0.1233
Average True Range 0.0161
ADX 24.43
+DI 23.9468
-DI 17.8271
Chandelier Exit (Long, 3 ATRs ) 0.1117
Chandelier Exit (Short, 3 ATRs ) 0.0983
Upper Bollinger Band 0.146
Lower Bollinger Band 0.0744
Percent B (%b) 0.57
BandWidth 64.972777
MACD Line -0.0032
MACD Signal Line -0.0052
MACD Histogram 0.002
Fundamentals Value
Market Cap 9.16 Million
Num Shares 79.7 Million
EPS -0.32
Price-to-Earnings (P/E) Ratio -0.37
Price-to-Sales 185.99
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.12
Resistance 3 (R3) 0.12 0.12 0.12
Resistance 2 (R2) 0.12 0.12 0.12 0.12
Resistance 1 (R1) 0.12 0.12 0.12 0.12 0.12
Pivot Point 0.12 0.12 0.12 0.12 0.12
Support 1 (S1) 0.11 0.11 0.11 0.11 0.11
Support 2 (S2) 0.11 0.11 0.11 0.11
Support 3 (S3) 0.11 0.11 0.11
Support 4 (S4) 0.11